Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2002 Dec 1;79(4):571–578. doi: 10.1093/jurban/79.4.571

Beliefs about methadone in an inner-city methadone clinic

Sharon Stancliff 1,✉, Julie Elana Myers, Stuart Steiner, Ernest Drucker
PMCID: PMC3456722  PMID: 12468676

Abstract

Despite being considered both the most effective treatment for beroin addiction and an essential tool in the prevention of buman immunodeficiency virus (HIV), methadone maintenance (MM) is often held in low esteem by beroin addicts—even those in MM treatment. This survey examined current beliefs and attitudes about MM of patients at an inner-city clinic, and the personal experience and attitudes of these patients with this treatment. Consenting patients in a methadone clinic serving a poor population with high rates of human immunodeficiency virus infection were queried about their attitudes toward and beliefs about methadone using a 16-item questionnaire. Over 2 days, 315 questionnaires were completed (acceptance rate 40%), totaling 32% of the 1000 clinic patients. Nearly 80% believed that methadone bad a positive effect on bis or ber life, but 80% were certain or unsure as to whether methadone is bad for one's bealth, and a similar percentage (80%) believed that discontinuing methadone was an important goal. Patients continue to have strongly negative attitudes toward and beliefs about methadone despite their acknowledgement that methadone has been very positive for them as individuals. As a result, many patients leave MM treatment prematurely, and there are usually unfilled slots in MM programs in New York City, even while continued need exists (e.g., less than 25% of the beroin addicts in the city are in treatment). The restrictive nature of many MM programs may account for these attitudes and beliefs.

Keywords: Addiction, Drug treatment, Heroin, HIV, Injection drug use, Methadone, New York City

Full Text

The Full Text of this article is available as a PDF (66.4 KB).

Footnotes

Weill Medical College of Cornell University; and Dr. Drucker is with Montefiore Medical Center/Albert Einstein College of Medicine.

References

  • 1.National Institutes of Health Effective medical treatment of opiate addiction. NIH Consensus Statement Online. 1997;15(6):1–38. [Google Scholar]
  • 2.Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(suppl A):S217–S230. [PubMed] [Google Scholar]
  • 3.Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(suppl 1):97–106. [PMC free article] [PubMed] [Google Scholar]
  • 4.Caplehorn JR, Dalton MS, Cluff MC, Petrenas AM. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 1994;89:203–209. doi: 10.1111/j.1360-0443.1994.tb00879.x. [DOI] [PubMed] [Google Scholar]
  • 5.Laine C, Markson LE, McKee LJ, Hauck WW, Fanning TR, Turner BJ. The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS. 1998;12:417–424. doi: 10.1097/00002030-199804000-00011. [DOI] [PubMed] [Google Scholar]
  • 6.Newschaffer CJ, Laine C, Hauck WW, Fanning T, Turner BJ. Clinic characteristics associated with reduced hospitalization of drug users with AIDS. J Urban Health. 1998;75:153–169. doi: 10.1007/BF02344936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Centers for Disease Control and Prevention. {jtHIV/AIDS Surveill Rep.} {dy2000};{vn12}({sn1}).
  • 8.Bureau of HIV/AIDS Epidemiology, New York State Department of Health . AIDS Surveillance Quarterly Update: Cases Reported Through June, 2000. NY: New York State Department of Health; 2000. [Google Scholar]
  • 9.Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule. Substance Abuse and Mental Health Services Administration. 66 (11) Federal Register (Wednesday, January 17, 2001), Rules and Regulations. [PubMed]
  • 10.Goldsmith DS, Hunt DE, Lipton DS, Strug DL. Methadone folklore: beliefs about side effects and their impact on treatment. Hum Organ. 1984;43:330–340. doi: 10.17730/humo.43.4.64m061v484th3871. [DOI] [Google Scholar]
  • 11.Hunt DE, Lipton DS, Goldsmith DS, Strug DL, Spunt B. It takes your heart”: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict. 1985;20:1751–1771. doi: 10.3109/10826088509047261. [DOI] [PubMed] [Google Scholar]
  • 12.Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs. 1991;23:21–27. doi: 10.1080/02791072.1991.10472571. [DOI] [PubMed] [Google Scholar]
  • 13.Murphy S, Irwin J. Living with the dirty secret”: problems of disclosure for methadone maintenance clients. J Psychoactive Drugs. 1992;24:257–264. doi: 10.1080/02791072.1992.10471646. [DOI] [PubMed] [Google Scholar]
  • 14.Zule WA, Desmond DP. Attitudes toward methadone maintenance: implications for HIV prevention. J Psychoactive Drugs. 1998;30:89–97. doi: 10.1080/02791072.1998.10399674. [DOI] [PubMed] [Google Scholar]
  • 15.D'Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: results from a panel study, 1988–1995. Am J Drug Alcohol Abuse. 1999;25:681–699. doi: 10.1081/ADA-100101886. [DOI] [PubMed] [Google Scholar]
  • 16.New York State Department of Health, AIDS Institute . Community Need Index for New York City HSA Region. Albany, NY: New York State Department of Health; 1995. [Google Scholar]
  • 17.Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illic drug use during treatment: methadone dose and visit frequency. Am J Public Health. 1998;88:34–39. doi: 10.2105/AJPH.88.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rettig RA, Yarmolinsky A, editors. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995. [PubMed] [Google Scholar]
  • 19.Narcotics Anonymous. World Services Regarding Methadone and Other Drug Replacement Programs. World Service Board of Trustees. Bulletin 29. Available at: www.na.org/bull29. htm. Date accessed: April 22, 2002.
  • 20.Koch M, Banys P. Liver transplantation and opioid dependence. JAMA. 2001;285:1056–1058. doi: 10.1001/jama.285.8.1056. [DOI] [PubMed] [Google Scholar]
  • 21.Caplehorn JR, Irwig L, Saunders JB. Attitudes and beliefs of staffworking in methadone maintenance clinics. Subst Use Misuse. 1996;31:437–452. doi: 10.3109/10826089609045820. [DOI] [PubMed] [Google Scholar]
  • 22.Caplehorn JR, Hartel DM, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse. 1997;32:399–413. doi: 10.3109/10826089709039361. [DOI] [PubMed] [Google Scholar]
  • 23.Magura S, Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med. 2001;68:62–74. [PubMed] [Google Scholar]
  • 24.Frank B. An overview of heroin trends in New York City; past, present and future. Mt Sinai J Med. 2000;67:340–346. [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES